<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Psychiatry</journal-id><journal-id journal-id-type="publisher-id">IJPS</journal-id><journal-title-group><journal-title>Iranian Journal of Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">1735-4587</issn><issn pub-type="epub">2008-2215</issn><publisher><publisher-name>Psychiatry &#x00026; Psychology Research Center, Tehran University of Medical Sciences</publisher-name><publisher-loc>Tehran, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26884782</article-id><article-id pub-id-type="pmc">4752528</article-id><article-id pub-id-type="publisher-id">IJPS-10-71</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>A Comparative Study of Group Behavioral Activation and Cognitive Therapy in Reducing Subsyndromal Anxiety and Depressive Symptoms</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Soleimani</surname><given-names>Mehdi</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mohammadkhani</surname><given-names>Parvaneh</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Dolatshahi</surname><given-names>Behroz</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Alizadeh</surname><given-names>Hamid</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Overmann</surname><given-names>Karenleigh A.</given-names></name><degrees>MA</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Coolidge</surname><given-names>Frederick L.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran</aff><aff id="aff2"><label>2</label>University of Social Welfare and Rehabilitation Sciences, Tehran, Iran</aff><aff id="aff3"><label>3</label>Allameh Tabataba&#x02019;i University, Tehran, Iran</aff><aff id="aff4"><label>4</label>Department of Psychology, University of Colorado, Colorado Springs, USA</aff><author-notes><corresp id="cor">Corresponding author: Mehdi Soleimani, PhD. Department of Psychiatry, Roozbeh Psychiatric hospital, Tehran University of Medical Sciences, Tehran, Iran, Tel:+98-2155419151.<email>soleimaniphd@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>2015</year></pub-date><volume>10</volume><issue>2</issue><fpage>71</fpage><lpage>78</lpage><permissions><copyright-statement>Copyright &#x000a9; Psychiatry &#x00026; Psychology Research Center, Tehran University of Medical Sciences</copyright-statement><license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>
<bold>Objective</bold>: This study compared the effectiveness of two group treatments, behavioral activation (BA) and cognitive therapy (CT), in reducing subsyndromal anxiety and depressive symptoms in a sample of Iranian university students.</p><p>
<bold>Method:</bold> Twenty-seven Iranian university students who scored 18 or higher on the depression subscale and 16 or higher on the anxiety subscale of the Depression, Anxiety, and Stress Scale (DASS-42) were randomly assigned into treatment groups. One group received 8 sessions of BA (n = 14), and the other received 8 sessions of group CT (n = 13).</p><p>
<bold>Result:</bold> Analysis of covariance revealed that the BA group had a significantly greater reduction in depressive symptoms than the CT group. However, there were no significant differences between the two groups in the levels of anxiety, stress symptoms or functional impairment after treatment.</p><p>
<bold>Conclusion:</bold> This study found evidence for the effectiveness of BA in reducing anxiety, depressive and stress symptoms and functional impairment compared to CT. BA was more effective than CT in improving depressive symptoms and was as effective as CT in decreasing anxiety, stress and functional impairment. BA is also a cost-effective intervention, particularly in group formats<bold>.</bold></p></abstract><kwd-group><title>Key Words</title><kwd><italic>Behavioral Activation Therapy</italic></kwd><kwd><italic>Cognitive Therapy</italic></kwd><kwd><italic>Subsyndromal Anxiety and Depressive Symptoms</italic></kwd><kwd><italic>Functional Impairment</italic></kwd></kwd-group></article-meta></front><body><p>According to the World Health Organization (WHO), anxiety and depressive disorders are the most common and prevalent mental disorders, with anxiety disorders as the most prevalent mental disorder (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). The rate of comorbidity between anxiety and depressive disorders is also significant (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). For example, the average rate of comorbidity between major depressive disorder and anxiety disorders exceeds 50% (<xref rid="B5" ref-type="bibr">5</xref>).</p><p>Subsyndromal anxiety and depression, though clinically failing to meet formal diagnostic criteria, has a significant potential to impair day-to-day functioning (<xref rid="B6" ref-type="bibr">6</xref>). Despite the fact that subsyndromal anxiety and depressive symptoms have a tendency to become chronic, they often receive little clinical attention, prompting the need to develop effective treatment strategies (<xref rid="B7" ref-type="bibr">7</xref>&#x02013;<xref rid="B9" ref-type="bibr">9</xref>). Moreover, patients with subsyndromal anxiety and depressive symptoms are at greater risk than the general population for developing clinical anxiety and depressive disorders when faced with psycho-social stressors (<xref rid="B10" ref-type="bibr">10</xref>).</p><p>Epidemiological studies have found an elevated rate of anxiety and depressive symptoms in university students in Iran (<xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>), with symptomatic severity interfering with students&#x02019; ability to function in the educational setting (<xref rid="B14" ref-type="bibr">14</xref>).</p><p>Cognitive therapy (CT) and behavior therapy have demonstrated effectiveness in treating anxiety and depressive disorders (<xref rid="B15" ref-type="bibr">15</xref>&#x02013;<xref rid="B17" ref-type="bibr">17</xref>). There is evidence suggesting that current psychotherapy models can reduce subsyndromal symptoms (<xref rid="B18" ref-type="bibr">18</xref>). Moreover, a new trend in the psychotherapy research, the transdiagnostic (unified) approach (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>), emphasizes the common etiology among emotional disorders, providing support for taking a dimensional (rather than categorical) approach to comorbid mental disorders (<xref rid="B21" ref-type="bibr">21</xref>). The transdiagnostic approach has several important features: It is easy to train clinicians to administer the interventions, it has the capacity to be implemented in a group setting, it can be applied to comorbid anxiety and depression, and it has demonstrated effectiveness in preventing relapse in recovery from emotional disorders (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). Furthermore, the transdiagnostic approach does not require formal clinical diagnosis of a psychiatric disorder (<xref rid="B22" ref-type="bibr">22</xref>).</p><p>Outcome studies have indicated the efficacy of CT for a variety of mental disorders, including major depressive disorder, generalized anxiety disorder, panic disorder and social anxiety disorder (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B24" ref-type="bibr">24</xref>). CT is also effective in the treatment of mixed anxiety&#x02013;depressive disorders (<xref rid="B25" ref-type="bibr">25</xref>) and in heterogeneous anxiety disorders in group format (<xref rid="B26" ref-type="bibr">26</xref>). Furthermore, preventive studies with at-risk populations indicate the potential effectiveness of CT-based programs (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>). Alternatively, medication (Fluvoxamine and Sertraline) has also demonstrated efficacy for treating mixed anxiety-depressive disorder in short-term periods (8 weeks) of treatment (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>).</p><p>Behavioral activation (BA) is a behaviorally-oriented psychotherapy that helps clients identify and modify inactivity and avoidance patterns (<xref rid="B31" ref-type="bibr">31</xref>). It was originally developed to treat depression (<xref rid="B32" ref-type="bibr">32</xref>) and has shown efficacy for treating this disorder (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B33" ref-type="bibr">33</xref>). BA has also been used to treat other disorders that are considered as emotion dysregulation, including anxiety disorders (<xref rid="B34" ref-type="bibr">34</xref>).</p><p>Avoidant behavior plays a key role in fostering and maintaining anxiety disorders and depression. For example, depressed patients are frequently involved in avoidant behaviors like complaining, which means they often lose any chance of gaining positive reinforcement (<xref rid="B35" ref-type="bibr">35</xref>). These insights into the connection between avoidant behavior and anxiety and depressive disorders inform both behavior therapy (which helps patients regulate their emotions by changing their behavior (<xref rid="B36" ref-type="bibr">36</xref>)) and exposure and response prevention (ERP, an empirically validated psychotherapy for anxiety disorders (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B37" ref-type="bibr">37</xref>)).</p><p>Because BA targets avoidant behaviors, the treatment is appropriate for managing comorbid anxiety and depression (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B38" ref-type="bibr">38</xref>). There is some early evidence showing that BA can decrease symptoms of posttraumatic stress disorder and comorbid major depressive disorder (<xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>). Pilot studies have shown that BA has positive effects in decreasing anxiety symptoms in chronic anxiety and coexistent depressive and anxiety symptoms (<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>). Chu and colleagues (<xref rid="B43" ref-type="bibr">43</xref>) also found that group BA therapy had clinical benefits for anxious and depressed young adolescents.</p><p>Group and short-term modalities yield several benefits, including cost-effectiveness and an ability to cover more patients than is possible with individual therapies or long-term treatments (<xref rid="B44" ref-type="bibr">44</xref>). Group and individual therapies have demonstrated similar effectiveness in treatment outcomes (<xref rid="B45" ref-type="bibr">45</xref>), and the reduced complexity of BA makes it consistent with the transdiagnostic approach (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B46" ref-type="bibr">46</xref>).</p><p>It is important to note that there have been a number of recent empirical studies that support the use of BA and CT in a variety of settings and populations (e.g., see <xref rid="B47" ref-type="bibr">47</xref>&#x02013;<xref rid="B56" ref-type="bibr">56</xref>). Thus, the purpose of this study was to compare the effectiveness of group BA treatment and group CT to reduce subsyndromal anxiety and depressive symptoms, stress symptoms and functional impairment in Iranian university students.</p><sec sec-type="materials|methods"><title>Material and Methods</title><p>
<italic>Participants</italic>
</p><p>Participants were Iranian university students (n = 32) recruited through advertisements in several universities in Tehran. This sample size was determined on the basis of Cohen&#x02019;s table (<xref rid="B57" ref-type="bibr">57</xref>) for a power of .08, alpha of .05, and an effect size of .80. The sample size exceeded the recommendation of Butler and colleagues (<xref rid="B24" ref-type="bibr">24</xref>), who suggest that a small number of participants (n = 9) is acceptable in studies of cognitive therapies for depression and anxiety. There were a total of 20 female participants, with 11 being assigned to the BA condition; of the seven male participants, three were assigned to the BA condition. The average age of the participants was 22 years for the BA condition and 23 years for the CT condition. Of the 14 participants assigned to the BA condition, only one was married, while in the 13 participants in the CT condition, two were married. These demographics are presented in <xref ref-type="table" rid="T1">Table 1</xref>.</p><p>Criteria for participant inclusion in the study were the existence of subsyndromal anxiety and depressive symptoms as measured by a score of 18 or higher on the depression subscale and 16 or higher on the anxiety subscale of the Depression, Anxiety and Stress Scale (DASS-42). This cutoff was selected to reflect the criteria used by Sahebi and colleagues (<xref rid="B58" ref-type="bibr">58</xref>) in their study on validating DASS-21 findings in a sample of an Iranian population, in which a score of 9 on the depression subscale and a score of 8 on the anxiety subscale of the DASS-21 indicated inclusion in the 75th percentile and a mild level of symptom severity. The items of the DASS-21 were selected to reflect all of the subscales, and the DASS-21subscale scores were multiplied by 2 to create the DASS-42 scales. Exclusion criteria were the existence of current Axis I disorders, including anxiety, depression, psychotic, somatoform or substance abuse, assessed by diagnostic interviews based on the Anxiety Disorders Interview Schedule for DSM-IV (ADIS-IV) (<xref rid="B59" ref-type="bibr">59</xref>) and simultaneously being on prescribed medication or in psychotherapy. All participants agreed to participate in the study and provided written informed consent.</p><p>The dropout criterion was three absences in eight sessions, consistent with the recommendation of Gollan and colleagues (<xref rid="B60" ref-type="bibr">60</xref>). Two participants dropped out of the BA condition, and three dropped out of the CT condition, reducing the total number of participants to 27. One participant left after two CT sessions due to dissatisfaction with the intervention relative to perceived needs. Another participant in the CT condition was unable to continue with the intervention following the death of a family member. Three other participants dropped out due to schedule conflicts.</p><p>
<italic>Materials and Procedure</italic>
</p><p>This study compared two groups of BA as the experimental condition and CT as the comparison condition. Participants were randomly assigned into one of the groups. CT was considered the comparison condition because of its demonstrated efficacy in treating depressive and anxiety disorders (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B17" ref-type="bibr">17</xref>) and its widespread use as a psychotherapeutic treatment (<xref rid="B62" ref-type="bibr">62</xref>). CT is also the most well-known and widely used psychotherapy in Iran, and its individual and group formats have been subjected to numerous investigations in treating Iranian patients (<xref rid="B63" ref-type="bibr">63</xref>&#x02013;<xref rid="B66" ref-type="bibr">66</xref>). Thus, the CT condition was considered to be the standard of comparison for the treatments in this study. CT presented the additional benefits of enabling control of non-specific therapeutic factors (e.g., contacting the therapist and attending treatment sessions) and provided an ethical treatment alternative for the comparison group.</p><p>Recruitment advertisements were placed at several Iranian universities. Volunteers were individually evaluated onsite to confirm their eligibility for the study and obtain informed consent. For determining eligibility, a clinical interview using ADIS-IV and DASS-42 was conducted for each participant. To measure functional impairment, the participants were asked to complete the Work and Social Adjustment Scale (WSAS) (<xref rid="B67" ref-type="bibr">67</xref>). Participants were then randomly assigned into either the BA or the CT treatment groups. Each treatment group consisted of 16 participants who received eight sessions of group intervention led by a trained therapist. To meet the recommended participant-to-therapist ratio (<xref rid="B68" ref-type="bibr">68</xref>), each group was further divided into two 8-member groups. One therapist conducted both BA subgroups, while the CT sessions had separate therapists for each subgroup. To ensure therapist compliance with the CT manual, peer supervision was used. Each CT therapist attended three sessions (sessions 1, 4, and 6) conducted by the other therapist as a co-therapist to monitor adherence to the manual. After each session, the two therapists discussed the session&#x02019;s process and content and provided recommendations to improve compliance with the manual. Finally, all participants completed the DASS-42 and the WSAS at the post-treatment assessment.</p><p>
<italic>Treatment and Therapists</italic>
</p><p>BA treatment followed the guidelines of Gollan and Martell and colleagues (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B61" ref-type="bibr">61</xref>) and consisted of eight group sessions. Each session had an agenda for the therapist to follow (outlined in <xref ref-type="table" rid="T2">Table 2</xref>) and lasted for 90 minutes. The primary goal of BA is to teach the participants to identify the patterns of behavior (especially avoidance behaviors) associated with anxiety and depressive symptoms, and to change the behaviors in ways that improve emotional regulation. Participants were encouraged to stop avoiding situations that led to feelings of anxiety and depression in favor of making changes that could positively alter emotional states. Participants were also encouraged to increase their level of life activity to increase their possibilities of feeling enjoyment and accomplishment.</p><p>CT followed the published guidelines (<xref rid="B68" ref-type="bibr">68</xref>). As in the BA condition, CT consisted of eight group sessions, each of which was implemented by a therapist according to a pre-established agenda (<xref ref-type="table" rid="T2">Table 2</xref>) and lasted for 90 minutes.</p><p>Participants in the CT condition were asked to identify relations between their thoughts and emotions, automatic thoughts and cognitive distortions. They were then encouraged to challenge them with cognitive techniques.</p><p>The two CT therapists were both PhD students in a clinical psychology program with at least 2 years of experience in the psychotherapy of anxiety and depressive disorders obtained in university counseling centers. They were also trained in cognitive behavioral therapy for the treatment of anxiety and depressive disorders. Prior to the study, they reviewed treatment manuals, and during the study, they received copies of session agendas.</p><p>
<italic>Measures</italic>
</p><p>
<italic>Anxiety, Depressive and Stress Symptoms</italic>: The Depression, Anxiety and Stress Scale (DASS) (<xref rid="B69" ref-type="bibr">69</xref>) was used to assess anxiety, depressive and stress symptoms. The DASS is a 42-item self-report questionnaire developed to measure three relevant emotions (depression, anxiety and stress). This questionnaire has a 21-item form. The measure is a valid and reliable instrument for the Iranian population, as assessed by Sahebi and colleagues (<xref rid="B58" ref-type="bibr">58</xref>) for the DASS-21 and by Bakhshipour and Dejkam (<xref rid="B70" ref-type="bibr">70</xref>) for the DASS-42. Sahebi and colleagues also established the construct validity of the DASS-21 in Iranian samples through factor analysis, and they found the internal reliability (Cronbach&#x02019;s &#x003b1;) of the DASS-21 in an adult Iranian sample of &#x003b1; = .77 for the depression subscale, &#x003b1; = .79 for anxiety subscale and &#x003b1; = .78 for stress subscale. Moreover, Bakhshipour and Dejkam reported &#x003b1; coefficients for the DASS-42 subscales, depression, anxiety and stress, respectively, of &#x003b1; = .97, &#x003b1; = .92, and &#x003b1; = .94. The construct validity of the DASS-42 was also established through factor analysis (<xref rid="B70" ref-type="bibr">70</xref>).</p><p>
<italic>Diagnostic Interview:</italic> The Anxiety Disorders Interview Schedule for DSM-IV (ADIS-IV) (<xref rid="B59" ref-type="bibr">59</xref>) was used to determine the diagnostic status of the participants. The ADIS-IV is a reliable structured interview designed to assess current anxiety disorders based on DSM-IV criteria. The ADIS-IV provides the possibility to assess current mood, somatoform and substance use disorders. The interview also screens for conversion and psychotic symptoms. Brown, Di Nardo, Lehman and Campbell (<xref rid="B71" ref-type="bibr">71</xref>) reported good reliability for the lifetime version of the ADIS-IV (ADIS-IV-L) based on kappa coefficients ranging from .58 to .81.</p><p>
<italic>Functional Impairment:</italic> In order to assess functional impairment, the five-item Work and Social Adjustment Scale (WSAS) was used, which has been shown to be a valid and reliable tool to assess anxiety and depressive disorders (<xref rid="B67" ref-type="bibr">67</xref>). We evaluated psychometric characteristics of the WSAS in a pilot study with a sample of Iranian university students (N = 67, age mean = 22.8 years, standard deviation of age = 2.3 years). According to this evaluation, there was a positive and significant Pearson correlation between the WSAS and the depression subscale of the DASS-21 and the Anxiety subscale of the DASS-21, respectively, r = .66, p &#x0003c; .001 and r = .66, p &#x0003c; .001. Test&#x02013;retest reliability in a one week period for the WSAS was r = .69, p &#x0003c; .001 (n = 32).</p></sec><sec sec-type="results"><title>Results</title><p>Participants who were assigned into the two conditions did not differ in their gender, age or marital status (<xref ref-type="table" rid="T1">Table 1</xref>).</p><p>Analysis of Variance (ANOVA) was used to determine the equivalence of the treatment conditions on outcome measures at the pretest point. </p><p>The results did not indicate a significant difference between BA and CT conditions on outcome measures at the pretest point for depressive symptoms, F(1, 25) = 1.13, p &#x0003e; .05; for anxiety symptoms, F(1, 25) = 0.02, p &#x0003e; .05; for stress symptoms, F(1, 25) = 1.44, p &#x0003e; .05; for functional impairment, F(1, 25) = 0.18, p &#x0003e; .05. These results demonstrated the success of random assignment in producing equivalent groups on these variables at the pretest point.</p><p>To analyze the effect of each treatment condition on outcome measures, the paired t test was used. Results are presented in <xref ref-type="table" rid="T3">Table 3</xref>. All paired t tests were significant at p &#x0003c; .01. These results indicated a significant difference between the pretest and posttest scores of each outcome measure in the BA and CT conditions, meaning that both treatments reduced the severity of depressive, anxiety and stress symptoms, as well as functional impairment.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Participant Characteristics by Treatment Condition</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="justify" rowspan="2" colspan="1">
<bold>Variable</bold>
</th><th align="center" colspan="3" rowspan="1">
<bold>Behavioral Activation (n = 14)</bold>
<hr/>
</th><th align="center" colspan="3" rowspan="1">
<bold>Cognitive Therapy (n = 13)</bold>
<hr/>
</th><th align="center" rowspan="2" colspan="1">
<bold>F(1, 25)</bold>
</th><th align="center" rowspan="2" colspan="1">
<bold>&#x003c7;</bold>
<sup>2</sup>
<bold>(N = 1, 27)</bold>
</th></tr><tr><th align="center" rowspan="1" colspan="1">
<bold>M (SD)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>n</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>%</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>M (SD)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>n</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>%</bold>
</th></tr></thead><tbody><tr><td align="justify" rowspan="3" colspan="1">Gender<break/>&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Female<break/>&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Male</td><td align="left" rowspan="3" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="3" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="3" colspan="1"/><td align="right" valign="middle" rowspan="3" colspan="1">.31</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">78.6</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">69.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">21.4</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">30.8</td></tr><tr><td align="justify" rowspan="1" colspan="1">Age </td><td align="left" colspan="2" rowspan="1">22.28 (3.07)</td><td align="left" rowspan="1" colspan="1"/><td align="left" colspan="2" rowspan="1">23.46 (3.41)</td><td align="left" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1">.89</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="3" colspan="1">Marriage<break/>&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Single<break/>&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Married</td><td align="left" rowspan="3" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="3" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="3" colspan="1"/><td align="right" valign="middle" rowspan="3" colspan="1">.46</td></tr><tr><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">92.0</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">84.6</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">7.1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">15.4</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Session Agenda by Treatment Condition</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2" colspan="1">
<bold>Session</bold>
</th><th align="center" colspan="2" rowspan="1">
<bold>Condition</bold>
<hr/>
</th></tr><tr><th align="center" rowspan="1" colspan="1">
<bold>Behavioral Activation</bold>
<xref ref-type="table-fn" rid="TFN1">a</xref>
</th><th align="center" rowspan="1" colspan="1">
<bold>Cognitive Therapy</bold>
<xref ref-type="table-fn" rid="TFN2">b</xref>
</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Negative emotions: Anxiety and depressive symptoms</td><td align="left" rowspan="1" colspan="1">The three systems model of human emotion and ABC model</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">BA model of anxiety and depression (the role of negative life events, avoidance from situations and others, and rumination in maintaining negative emotions)</td><td align="left" rowspan="1" colspan="1">Cognitive theory of anxiety and depression (core beliefs, automatic thoughts, negative cognitive triad, and logical errors)</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Pleasure-accomplishment rating and developing a pleasure activity chart</td><td align="left" rowspan="1" colspan="1">Thought injection and vertical arrow procedure</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">ACTION skill</td><td align="left" rowspan="1" colspan="1">Advanced vertical arrow and categorizing beliefs</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">TRAP and TRAC skill</td><td align="left" rowspan="1" colspan="1">Changeability of beliefs, objective analysis, and utility analysis</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Stress, depression and anxiety</td><td align="left" rowspan="1" colspan="1">Logical analysis</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">Assertiveness</td><td align="left" rowspan="1" colspan="1">countering</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">Review of program and maintenance plan</td><td align="left" rowspan="1" colspan="1">Review of program and maintenance plan</td></tr></tbody></table><table-wrap-foot><p>Note<italic>:</italic> ABC = activating event, belief and emotional consequences; ACTION = assess, choose, try, integrate, observe result and never give up; TRAP = trigger, response and avoidance pattern; TRAC = trigger, response and alternative coping.</p><fn id="TFN1"><label>a</label><p> Adapted from (60).</p></fn><fn id="TFN2"><label>b</label><p> Adapted from (68).</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Means, Standard Deviations and ANCOVA Results for the Outcome Measures</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="3" colspan="1">
<bold>Variable</bold>
</th><th align="center" colspan="3" rowspan="1">
<bold>Behavioral Activation (n = 14)</bold>
<hr/>
</th><th align="center" colspan="3" rowspan="1">
<bold>Cognitive Therapy (n = 13)</bold>
<hr/>
</th><th align="center" valign="middle" rowspan="3" colspan="1">
<bold>F(1,24)</bold>
</th></tr><tr><th align="center" rowspan="1" colspan="1">
<bold>Pretest</bold>
<hr/>
</th><th align="center" rowspan="1" colspan="1">
<bold>Posttest</bold>
<hr/>
</th><th align="center" valign="middle" rowspan="2" colspan="1">
<bold>Paired </bold>
<break/>
<bold>t(13)</bold>
<xref ref-type="table-fn" rid="TFN3">a</xref>
</th><th align="center" rowspan="1" colspan="1">
<bold>Pretest</bold>
<hr/>
</th><th align="center" rowspan="1" colspan="1">
<bold>Posttest</bold>
<hr/>
</th><th align="center" rowspan="2" colspan="1">
<bold>Paired </bold>
<break/>
<bold>t(12)</bold>
<xref ref-type="table-fn" rid="TFN3">a</xref>
</th></tr><tr><th align="center" rowspan="1" colspan="1">
<bold>M (SD)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>M (SD)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>M (SD)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>M (SD)</bold>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">DASS-D</td><td align="center" rowspan="1" colspan="1">23.71(3.83)</td><td align="center" rowspan="1" colspan="1">12.36(5.98)</td><td align="center" rowspan="1" colspan="1">8.19</td><td align="center" rowspan="1" colspan="1">22.15(3.78)</td><td align="center" rowspan="1" colspan="1">16.46(4.52)</td><td align="center" rowspan="1" colspan="1">4.81</td><td align="center" rowspan="1" colspan="1">7.80<xref ref-type="table-fn" rid="TFN4">b</xref></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">DASS-A</td><td align="center" rowspan="1" colspan="1">20.93(4.03)</td><td align="center" rowspan="1" colspan="1">12.57(5.12)</td><td align="center" rowspan="1" colspan="1">6.97</td><td align="center" rowspan="1" colspan="1">20.69(3.68)</td><td align="center" rowspan="1" colspan="1">11.46(4.05)</td><td align="center" rowspan="1" colspan="1">5.99</td><td align="center" rowspan="1" colspan="1">.35</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">DASS-S</td><td align="center" rowspan="1" colspan="1">20.50(4.52)</td><td align="center" rowspan="1" colspan="1">13.21(3.26)</td><td align="center" rowspan="1" colspan="1">6.80</td><td align="center" valign="bottom" rowspan="1" colspan="1">18.54(3.93)</td><td align="center" rowspan="1" colspan="1">11.77(2.98)</td><td align="center" rowspan="1" colspan="1">5.94</td><td align="center" rowspan="1" colspan="1">.48</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">WSAS</td><td align="center" rowspan="1" colspan="1">19.93(6.13)</td><td align="center" rowspan="1" colspan="1">13.14(6.69)</td><td align="center" rowspan="1" colspan="1">3.48</td><td align="center" rowspan="1" colspan="1">18.85(7.02)</td><td align="center" rowspan="1" colspan="1">12.54(5.78)</td><td align="center" rowspan="1" colspan="1">4.74</td><td align="center" rowspan="1" colspan="1">.00</td></tr></tbody></table><table-wrap-foot><p>Note<italic>: </italic>DASS-D = depression subscale of the DASS; DASS-A = anxiety subscale of the DASS; DASS-S = stress subscale of the DASS; WSAS = functional impairment.</p><fn id="TFN3"><label>a</label><p> All paired t values were significant at p &#x0003c; .01.</p></fn><fn id="TFN4"><label>b</label><p> p &#x0003c; .05.</p></fn></table-wrap-foot></table-wrap><p>To compare the BA and CT conditions on the outcome measures, Analysis of Covariance (ANCOVA) was used with pretest scores as the covariate. The ANCOVA results and the means and standard deviations of the outcome measures at the pretest and posttest points are presented in <xref ref-type="table" rid="T3">Table 3</xref>. </p><p>The BA condition showed a significantly higher effectiveness relative to the CT condition in treating depressive symptoms, F(1, 24) = 7.80, p &#x0003c; .05, partial &#x003b7;<sup>2</sup> = .24 (a large effect), but there was no difference between the two treatment conditions in improving anxiety and stress symptoms or functional impairment (p &#x0003e; .05) for anxiety symptoms, partial &#x003b7;<sup>2</sup>= .01; for stress symptoms, partial &#x003b7;<sup>2</sup>= .02; for functional impairment, partial &#x003b7;<sup>2</sup>= .00. The effect size (Cohen&#x02019;s d) for BA relative to CT was also calculated from the ANCOVA F value (<xref rid="B72" ref-type="bibr">72</xref>): For depressive symptoms, d = &#x02013;0.86; for anxiety symptoms, d = 0.21; for stress symptoms, d = 0.24; for functional impairment, d = 0.01. A negative d score was interpreted as indicating the greater effectiveness of BA relative to CT, and a positive d score as indicating the greater effectiveness of CT relative to BA.</p><p>According to the definition of a clinically significant change (<xref rid="B73" ref-type="bibr">73</xref>), two treatment conditions were compared to determine whether either one moved participants from the range considered dysfunctional to the range assessed as functional. Based on the normative data on the Iranian population for the DASS provided by Sahebi and colleagues (<xref rid="B58" ref-type="bibr">58</xref>), cutoff points between the normal level and the level of mild symptom severity were selected for the three subscales. Where Sahebi and colleagues reported different cutoff points for men and women, the present study established different cutoff points to assess the percentage of participants in each condition indicating a clinically significant change in symptom severity.</p><p>For depressive symptoms, 71% of the participants of BA condition (n = 10) were assessed to be in the functional range, compared with 31% of CT participants (n = 4). For anxiety symptoms, 50% of BA participants (n = 7) showed a clinically significant improvement in symptoms, compared to 61% of the CT participants (n = 8). Finally, all participants in both conditions reached the functional range in stress symptoms.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>This study compared the effectiveness of BA and CT administered in group settings in university students with subsyndromal anxiety and depressive symptoms. The results revealed that both treatments could decrease the severity of symptoms and functional impairments in participants. However, BA was more effective than CT in reducing depressive symptoms as assessed through both statistical and clinical significance. This finding was consistent with a previous, large sample investigation (<xref rid="B33" ref-type="bibr">33</xref>) that found BA was more effective than CT in treating severely depressed patients. The effect size reported by Dimidjian and colleagues (<xref rid="B33" ref-type="bibr">33</xref>) for the Beck Depression Inventory (BDI) was 0.87 (a large effect), which was comparable to the effect size found by the present study (d = 0.86). In addition to demonstrating greater effectiveness in managing depressive symptoms relative to CT, BA has several advantages. Jacobson and colleagues (<xref rid="B46" ref-type="bibr">46</xref>) demonstrated that the BA component of the full CT protocol can be as effective as the full CT protocol, making it easier and less costly to implement. Furthermore, BA is more easily applied to patients and trained in therapists than CT (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B33" ref-type="bibr">33</xref>).</p><p>BA and CT were similarly effective in reducing anxiety, stress symptoms and functional impairment. The finding of this study revealed that BA effectively reduced anxiety symptoms, which is consistent with previous studies (<xref rid="B41" ref-type="bibr">41</xref>&#x02013;<xref rid="B43" ref-type="bibr">43</xref>), and it is noteworthy because currently there is only one technique in the BA manual that directly addresses anxiety issues and prescribes exposure treatment. Although there were no in vivo exposure exercises in BA sessions, therapists encouraged participants to expose and stop avoiding. Of course, the characteristics of the present sample might limit the generalization of these findings.</p><p>
<italic>Limitations and Future Directions</italic>
</p><p>This was a pilot study; and as a result, there were several limitations. First, the sample size was not large, possibly limiting the generalizability of the results. Therefore, future studies should consider increasing the sample size to improve generalizability. Second, the CT condition in the present study was a subset rather than the full protocol, and this may limit its effectiveness, which can be increased when implemented with other techniques in the complete CT protocol. Finally, the sample was taken from a specific, highly educated population, and the findings might be limited to this population. Future studies should compare the BA and CT interventions on other populations, including clinical samples. Furthermore, it may be useful to investigate the preventive effect of BA and explore the mechanisms of change in the intervention.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Participants in the present study had subsyndromal symptoms of anxiety and depression. As noted previously, these symptoms can lead to the significant functional impairments (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B14" ref-type="bibr">14</xref>). As found by this study, BA is an effective treatment for these symptoms and may be preferable to CT in terms of cost and ease of implementation. On the other hand, medications are often prescribed for these symptoms (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>), with CT being the most commonly prescribed form of psychotherapy (<xref rid="B62" ref-type="bibr">62</xref>), so patients suffering from these symptoms are likely to receive CT treatment interventions in clinical settings. Thus, this study offers BA as an effective alternative to CT in clinical settings.</p><p>The effects of both treatments on anxiety and depressive symptoms indirectly support the notion that a common etiology underlies depressive and anxiety disorders, and it is consistent with the transdiagnostic approach (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>) to go beyond the current diagnostic categories and develop simpler intervention.</p><p>In summary, this study found positive evidence for the effectiveness of BA in reducing anxiety, depressive and stress symptoms and functional impairment relative to CT. BA was more effective than CT in improving depressive symptoms and was as effective as CT in decreasing anxiety, stress and functional impairment. BA is also a cost-effective intervention, particularly in group formats for clients and managed care.</p></sec></body><back><ack><title>Acknowledgment</title><p>This investigation was conducted as Mehdi Soleimani&#x02019;s PhD dissertation at the University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.</p></ack><sec><title>Conflict of interest</title><p>There were no conflicts of interest.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Chiu</surname><given-names>WT</given-names></name><name><surname>Demler</surname><given-names>O</given-names></name><name><surname>Walters</surname><given-names>EE</given-names></name></person-group><article-title>Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication</article-title><source> Arch Gen Psychiat</source><year>2005</year><volume>62</volume><fpage>617</fpage><lpage>627</lpage><pub-id pub-id-type="pmid">15939839</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>KG</given-names></name></person-group><article-title>Rising rates of depression in today&#x02019;s society: consideration of roles of effort-based rewards and enhanced resilience in day-to-day functioning</article-title><source>Neurosci Biobehav R</source><year>2006</year><volume>30</volume><fpage>497</fpage><lpage>510</lpage></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>TA</given-names></name><name><surname>Campbell</surname><given-names>LA</given-names></name><name><surname>Lehman</surname><given-names>CL</given-names></name><name><surname>Grisham</surname><given-names>JR</given-names></name><name><surname>Mancill</surname><given-names>RB</given-names></name></person-group><article-title>Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample</article-title><source>J Abnorm Psychol</source><year>2001</year><volume>110</volume><fpage>585</fpage><lpage>599</lpage><pub-id pub-id-type="pmid">11727948</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>BJ</given-names></name><name><surname>Clara</surname><given-names>IP</given-names></name><name><surname>Enns</surname><given-names>MW</given-names></name></person-group><article-title>Posttraumatic stress disorder and the structure of common mental disorders</article-title><source>Depress Anxiety</source><year>2002</year><volume>15</volume><fpage>168</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">12112721</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mineka</surname><given-names>S</given-names></name><name><surname>Watson</surname><given-names>D</given-names></name><name><surname>Clark</surname><given-names>LA</given-names></name></person-group><article-title>Comorbidity of anxiety and unipolar mood disorders</article-title><source>Annu Rev Psychol</source><year>1998</year><volume>49</volume><fpage>377</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">9496627</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dozois</surname><given-names>DJA</given-names></name><name><surname>Westra</surname><given-names>HA</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Dozois</surname><given-names>DJA</given-names></name><name><surname>Dobson</surname><given-names>KS</given-names></name></person-group><article-title>The nature of anxiety and depression: implications for prevention</article-title><source>The prevention of anxiety and depression: the theory, research, and practice</source><year>2004</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>American Psychological Association</publisher-name></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldney</surname><given-names>RD</given-names></name><name><surname>Fisher</surname><given-names>LJ</given-names></name><name><surname>Dal</surname><given-names>Grande E</given-names></name><name><surname>Taylor</surname><given-names>AW</given-names></name></person-group><article-title>Subsyndromal depression: prevalence, use of health services and quality of life in an Australian population</article-title><source> Soc Psych Psych Epid</source><year>2004</year><volume>39</volume><fpage>293</fpage><lpage>298</lpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavretsky</surname><given-names>H</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name></person-group><article-title>Clinically significant non-major depression: old concepts, new insights</article-title><source> Am J Geriat Psychiat</source><year>2002</year><volume>10</volume><fpage>239</fpage><lpage>255</lpage></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivas-Vazquez</surname><given-names>RA</given-names></name><name><surname>Saffa-Biller</surname><given-names>D</given-names></name><name><surname>Ruiz</surname><given-names>I</given-names></name><name><surname>Blais</surname><given-names>MA</given-names></name><name><surname>Rivas-Vazquez</surname><given-names>A</given-names></name></person-group><article-title>Current issues in anxiety and depression: comorbid, mixed, and subthreshold disorders</article-title><source> Professional Psychology: Research and Practice</source><year>2004</year><volume>35</volume><fpage>74</fpage><lpage>83</lpage></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katon</surname><given-names>W</given-names></name><name><surname>Roy-Byrne</surname><given-names>P</given-names></name></person-group><article-title>Mixed anxiety and depression</article-title><source>J Abnorm Psychol</source><year>1991</year><volume>100</volume><fpage>337</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">1918612</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Amini</surname><given-names>F</given-names></name><name><surname>Farhadi</surname><given-names>A</given-names></name></person-group><source>The prevalence of anxiety and depression, and their effects on educational performance among university students of Lorestan medical university. Abstract Collection of First Seminar on Mental Health of University Students</source><year>2001</year><publisher-loc>Tehran</publisher-loc><publisher-name>University of Tehran</publisher-name></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mosayebi</surname><given-names>A</given-names></name><name><surname>Verhram</surname><given-names>F</given-names></name><name><surname>Behbahani</surname><given-names>AA</given-names></name><name><surname>Shamloo</surname><given-names>F</given-names></name><name><surname>Javadi</surname><given-names>M</given-names></name></person-group><source>The study of personality type, depression and anxiety rate with self-report questionnaires in medical, dental, &#x00026; nursing students. Thesis for medical degree</source><year>1995</year><publisher-loc>Ghazvin</publisher-loc><publisher-name>Ghazvin Medical University</publisher-name></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Narimani</surname><given-names>M</given-names></name></person-group><source>The prevalence and causes of anxiety in Mohaghghegh Ardabili&#x02019;s university students. Abstract Collection of First Seminar on Mental Health of University Students</source><year>2001</year><publisher-loc>Tehran</publisher-loc><publisher-name>University of Tehran</publisher-name></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sohrabi</surname><given-names>F</given-names></name><name><surname>Nobakht</surname><given-names>M</given-names></name></person-group><source>The relationship between mental health and educational achievement in Tehran university students. Abstract Collection of First Seminar on Mental Health of University Student</source><year>2001</year><publisher-loc>Tehran</publisher-loc><publisher-name>University of Tehran</publisher-name></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambless</surname><given-names>DL</given-names></name><name><surname>Baker</surname><given-names>MJ</given-names></name><name><surname>Baucom</surname><given-names>DH</given-names></name><name><surname>Beutler</surname><given-names>LE</given-names></name><name><surname>Calhoun</surname><given-names>KS</given-names></name><name><surname>Crits-Christoph</surname><given-names>P</given-names></name><etal/></person-group><article-title>Update on empirically validated therapies, II.</article-title><source>The Clinical Psychologist</source><year>1998</year><volume>51</volume><fpage>3</fpage><lpage>16</lpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambless</surname><given-names>DL</given-names></name><name><surname>Ollendick</surname><given-names>TH</given-names></name></person-group><article-title>Empirically supported psychological interventions: controversies and evidence</article-title><source> Annu Rev Psychol</source><year>2001</year><volume>52</volume><fpage>685</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">11148322</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><collab>Task Force on Promotion and Dissemination of Psychological Procedures</collab><article-title>Training in and dissemination of empirically-validated psychological treatments</article-title><source>The Clinical Psychologist</source><year>1995</year><volume>48</volume><fpage>3</fpage><lpage>23</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkham</surname><given-names>M</given-names></name><name><surname>Shapiro</surname><given-names>DA</given-names></name><name><surname>Hardly</surname><given-names>GE</given-names></name><name><surname>Rees</surname><given-names>A</given-names></name></person-group><article-title>Psychotherapy in two-plus-one sessions: outcomes of a randomized controlled trial of cognitive&#x02013;behavioral and psychodynamic&#x02013;interpersonal therapy for subsyndromal depression</article-title><source>J Consult Clin Psych</source><year>1999</year><volume>67</volume><fpage>201</fpage><lpage>211</lpage></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norton</surname><given-names>PJ</given-names></name></person-group><article-title>An open trial of transdiagnostic cognitive-behavioral group therapy for anxiety disorders</article-title><source>Behav Ther</source><year>2008</year><volume>39</volume><fpage>242</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">18721638</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norton</surname><given-names>PJ</given-names></name><name><surname>Hayes</surname><given-names>SA</given-names></name><name><surname>Hope</surname><given-names>DA</given-names></name></person-group><article-title>Effects of a transdiagnostic group treatment for anxiety on secondary depressive disorders</article-title><source>Depress Anxiety</source><year>2004</year><volume>20</volume><fpage>198</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">15643648</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>BA</given-names></name><name><surname>McHugh</surname><given-names>RK</given-names></name><name><surname>Barlow</surname><given-names>DH</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Barlow</surname><given-names>DH</given-names></name></person-group><article-title>Emotional disorders: a unified approach</article-title><source>Clinical handbook of psychological disorders: a step-by-step treatment manual</source><year>2007</year><edition>4th ed.</edition><publisher-loc>New York</publisher-loc><publisher-name>Guilford</publisher-name></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>DA</given-names></name><name><surname>Taylor</surname><given-names>S</given-names></name></person-group><article-title>The transdiagnostic perspective on cognitive-behavioral therapy for anxiety and depression: new wine for old wineskins?</article-title><source>Journal of Cognitive Psychotherapy</source><year>2009</year><volume>23</volume><fpage>60</fpage><lpage>66</lpage></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dozois</surname><given-names>DA</given-names></name><name><surname>Seeds</surname><given-names>PM</given-names></name><name><surname>Collins</surname><given-names>KA</given-names></name></person-group><article-title>Transdiagnostic approaches to the prevention of depression and anxiety</article-title><source>Journal of Cognitive Psychotherapy</source><year>2009</year><volume>23</volume><fpage>44</fpage><lpage>59</lpage></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>AC</given-names></name><name><surname>Chapman</surname><given-names>JE</given-names></name><name><surname>Forman</surname><given-names>EM</given-names></name><name><surname>Beck</surname><given-names>AT</given-names></name></person-group><article-title>The empirical status of cognitive-behavioral therapy: a review of meta-analyses</article-title><source>Clin Psychol Rev</source><year>2006</year><volume>26</volume><fpage>17</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">16199119</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Echeburua</surname><given-names>E</given-names></name><name><surname>Salaberria</surname><given-names>K</given-names></name><name><surname>Corral</surname><given-names>P</given-names></name><name><surname>Cenea</surname><given-names>R</given-names></name><name><surname>Berasategui</surname><given-names>T</given-names></name></person-group><article-title>Treatment of mixed anxiety&#x02013;depression disorder: long-term outcome</article-title><source>Behav Cogn Psychoth</source><year>2006</year><volume>34</volume><fpage>95</fpage><lpage>101</lpage></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erickson</surname><given-names>DH</given-names></name></person-group><article-title>Group cognitive behavioural therapy for heterogeneous anxiety disorders</article-title><source>Cognitive Behaviour Therapy</source><year>2003</year><volume>32</volume><fpage>179</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">16291549</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konnert</surname><given-names>C</given-names></name><name><surname>Dobson</surname><given-names>K</given-names></name><name><surname>Stelmach</surname><given-names>L</given-names></name></person-group><article-title>The prevention of depression in nursing home residents: a randomized clinical trial of cognitive-behavioral therapy</article-title><source>Aging Ment Health</source><year>2009</year><volume>13</volume><fpage>288</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">19347696</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stice</surname><given-names>E</given-names></name><name><surname>Burton</surname><given-names>E</given-names></name><name><surname>Bearman</surname><given-names>SK</given-names></name><name><surname>Rohde</surname><given-names>P</given-names></name></person-group><article-title>Randomized trial of a brief depression prevention program: an elusive search for a psychosocial placebo control condition</article-title><source>Behav Res Ther</source><year>2007</year><volume>45</volume><fpage>863</fpage><lpage>876</lpage><pub-id pub-id-type="pmid">17007812</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrasco</surname><given-names>JL</given-names></name><name><surname>D&#x000ed;az-Mars&#x000e1;</surname><given-names>M</given-names></name><name><surname>S&#x000e1;iz-Ruiz</surname><given-names>J</given-names></name></person-group><article-title>Sertraline in the treatment of mixed anxiety and depression disorder</article-title><source>J Affect Disorders</source><year>2000</year><volume>59</volume><fpage>67</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">10814773</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousch</surname><given-names>JL</given-names></name><name><surname>MacHobby</surname><given-names>H</given-names></name><name><surname>Shendarkar</surname><given-names>N</given-names></name><name><surname>Johnson</surname><given-names>ME</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis</article-title><source>Journal of Clinical Psychopharmachology</source><year>2001</year><volume>21</volume><fpage>139</fpage><lpage>142</lpage></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Martell</surname><given-names>CR</given-names></name><name><surname>Addis</surname><given-names>ME</given-names></name><name><surname>Jacobson</surname><given-names>NS</given-names></name></person-group><source>Depression in context: strategies for guided action</source><year>2001</year><publisher-loc>New York</publisher-loc><publisher-name>Norton</publisher-name></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobson</surname><given-names>NS</given-names></name><name><surname>Martell</surname><given-names>CR</given-names></name><name><surname>Dimidjian</surname><given-names>S</given-names></name></person-group><article-title>Behavioral activation treatment for depression: returning to contextual roots</article-title><source>Clin Psychol&#x02014;Sci Pr</source><year>2001</year><volume>8</volume><fpage>255</fpage><lpage>270</lpage></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimidjian</surname><given-names>S</given-names></name><name><surname>Hollon</surname><given-names>SD</given-names></name><name><surname>Dobson</surname><given-names>KS</given-names></name><name><surname>Schmaling</surname><given-names>KB</given-names></name><name><surname>Kohlenberg</surname><given-names>RJ</given-names></name><name><surname>Addis</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression</article-title><source>J Consult Clin Psych</source><year>2006</year><volume>74</volume><fpage>658</fpage><lpage>670</lpage></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Syzdek</surname><given-names>MR</given-names></name><name><surname>Addis</surname><given-names>ME</given-names></name><name><surname>Martell</surname><given-names>CR</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Kring</surname><given-names>AM</given-names></name><name><surname>Sloan</surname><given-names>DM</given-names></name></person-group><article-title>Working with emotion and emotion regulation in behavioral activation treatment for depressed mood</article-title><source>Emotion regulation and psychopathology: a transdiagnostic approach to etiology and treatment</source><year>2010</year><publisher-loc>New York</publisher-loc><publisher-name>Guilford</publisher-name></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferster</surname><given-names>CB</given-names></name></person-group><article-title>A functional analysis of depression</article-title><source>Am Psychol</source><year>1973</year><volume>28</volume><fpage>857</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">4753644</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mowrer</surname><given-names>OH</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Mowrer</surname><given-names>OH</given-names></name></person-group><article-title>Two-factor learning theory: versions one and two</article-title><source>Learning theory and behavior</source><year>1960</year><publisher-loc>Hoboken</publisher-loc><publisher-name>Wiley</publisher-name></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Foa</surname><given-names>E</given-names></name><name><surname>Franklin</surname><given-names>M</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Barlow</surname><given-names>DH</given-names></name></person-group><article-title>Obsessive&#x02013;compulsive disorder</article-title><source>Clinical handbook of psychological disorders: a step-by-step treatment manual</source><year>2001</year><edition>3rd ed.</edition><publisher-loc>New York</publisher-loc><publisher-name>Guilford Press</publisher-name></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopko</surname><given-names>DR</given-names></name><name><surname>Robertson</surname><given-names>SMC</given-names></name><name><surname>Lejuez</surname><given-names>CW</given-names></name></person-group><article-title>Behavioral activation for anxiety disorders</article-title><source>The Behavior Analyst Today</source><year>2006</year><volume>7</volume><fpage>212</fpage><lpage>224</lpage></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakupack</surname><given-names>M</given-names></name><name><surname>Roberts</surname><given-names>LJ</given-names></name><name><surname>Yoshimoto</surname><given-names>D</given-names></name><name><surname>Mulick</surname><given-names>PS</given-names></name><name><surname>Martell</surname><given-names>C</given-names></name><name><surname>Balsam</surname><given-names>KF</given-names></name><etal/></person-group><article-title>Behavioral activation for the treatment of PTSD</article-title><source>J Trauma Stress</source><year>2006</year><volume>19</volume><fpage>387</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">16789005</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>AP</given-names></name><name><surname>Jakupcak</surname><given-names>M</given-names></name></person-group><article-title>Behavioral activation for treatment of PTSD and depression in an Iraq combat veteran with multiple physical injuries</article-title><source> Behav Cogn Psychoth</source><year>2010</year><volume>38</volume><fpage>355</fpage><lpage>361</lpage></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopko</surname><given-names>DR</given-names></name><name><surname>Lejuez</surname><given-names>CW</given-names></name><name><surname>Hopko</surname><given-names>SD</given-names></name></person-group><article-title>Behavioral activation as an intervention for coexistent depressive and anxiety symptoms</article-title><source>Clinical Case Studies</source><year>2004</year><volume>3</volume><fpage>37</fpage><lpage>48</lpage></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>JS</given-names></name><name><surname>Leach</surname><given-names>JD</given-names></name></person-group><article-title>Brief behavioral activation treatment of chronic anxiety in an older adult</article-title><source>Behav Change</source><year>2009</year><volume>26</volume><fpage>214</fpage><lpage>222</lpage></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>BC</given-names></name><name><surname>Colognori</surname><given-names>D</given-names></name><name><surname>Weissman</surname><given-names>AS</given-names></name><name><surname>Bannon</surname><given-names>K</given-names></name></person-group><article-title>An initial description and pilot of group behavioral activation therapy for anxious and depressed youth</article-title><source>Cogn Behav Pract</source><year>2009</year><volume>16</volume><fpage>408</fpage><lpage>419</lpage></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kazdin</surname><given-names>AE</given-names></name></person-group><source>Research design in clinical psychology</source><year>1992</year><edition>2nd ed</edition><publisher-loc>Boston</publisher-loc><publisher-name>Allyn &#x00026; Bacon</publisher-name></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McRoberts</surname><given-names>C</given-names></name><name><surname>Burlingame</surname><given-names>GM</given-names></name><name><surname>Hoag</surname><given-names>MJ</given-names></name></person-group><article-title>Comparative efficacy of individual and group psychotherapy: a meta-analytic perspective</article-title><source>Group Dyn&#x02013;Theory Res</source><year>1998</year><volume>2</volume><fpage>101</fpage><lpage>117</lpage></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobson</surname><given-names>NS</given-names></name><name><surname>Dobson</surname><given-names>KS</given-names></name><name><surname>Truax</surname><given-names>PA</given-names></name><name><surname>Addis</surname><given-names>ME</given-names></name><name><surname>Koerner</surname><given-names>K</given-names></name><name><surname>Gollan</surname><given-names>JK</given-names></name><etal/></person-group><article-title>A component analysis of cognitive-behavioral treatment for depression</article-title><source>J Consult Clin Psych</source><year>1996</year><volume>64</volume><fpage>295</fpage><lpage>304</lpage></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masterson</surname><given-names>C</given-names></name><name><surname>Ekers</surname><given-names>D</given-names></name><name><surname>Gilbody</surname><given-names>S</given-names></name><name><surname>Richards</surname><given-names>D</given-names></name><name><surname>Toner-Clewes</surname><given-names>B</given-names></name><name><surname>McMillan</surname><given-names>D</given-names></name></person-group><article-title>Sudden gains in behavioural activation for depression</article-title><source>Behav Res Ther</source><year>2014</year><volume>60</volume><fpage>34</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">25049140</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanter</surname><given-names>JW</given-names></name><name><surname>Santiago-Rivera</surname><given-names>AL</given-names></name><name><surname>Santos</surname><given-names>MM</given-names></name><name><surname>Nagy</surname><given-names>G</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>M</given-names></name><name><surname>Hurtado</surname><given-names>GB</given-names></name><etal/></person-group><article-title>A randomized hybrid efficacy and effectiveness trial of behavioral activation for Latinos with depression</article-title><source>Behav Ther (in press)</source><comment>Available online 28 September 2014</comment></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folke</surname><given-names>F</given-names></name><name><surname>Hursti</surname><given-names>T</given-names></name><name><surname>Tungstr&#x000f6;m</surname><given-names>S</given-names></name><name><surname>S&#x000f6;derberg</surname><given-names>P</given-names></name><name><surname>Ekselius</surname><given-names>L</given-names></name><name><surname>Kanter</surname><given-names>JW</given-names></name></person-group><article-title>Behavioral activation between acute inpatient and outpatient psychiatry: description of a protocol and a pilot feasibility study</article-title><source>Cogn Behav Pract (in press)</source><comment>Available online 2 May 2014</comment></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chartier</surname><given-names>IS</given-names></name><name><surname>Provencher</surname><given-names>MD</given-names></name></person-group><article-title>Behavioural activation for depression: efficacy, effectiveness and dissemination</article-title><source>J Affect Disorders</source><year>2013</year><volume>145</volume><fpage>292</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">22884236</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Rapee</surname><given-names>RM</given-names></name><name><surname>Pillay</surname><given-names>P</given-names></name></person-group><article-title>Behavioural activation: a pilot trial of transdiagnostic treatment for excessive worry</article-title><source>Behav Res Ther</source><year>2013</year><volume>51</volume><fpage>533</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">23827657</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mewton</surname><given-names>L</given-names></name><name><surname>Andrews</surname><given-names>G</given-names></name></person-group><article-title>Cognitive behaviour therapy via the internet for depression: a useful strategy to reduce suicidal ideation</article-title><source>J Affect Disorders</source><year>2015</year><volume>170</volume><fpage>78</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">25233243</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newby</surname><given-names>JM</given-names></name><name><surname>Williams</surname><given-names>AD</given-names></name><name><surname>Andrews</surname><given-names>G</given-names></name></person-group><article-title>Reductions in negative repetitive thinking and metacognitive beliefs during transdiagnostic Internet cognitive behavioural therapy (iCBT) for mixed anxiety and depression</article-title><source>Behav Res Ther</source><year>2014</year><volume>59</volume><fpage>52</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">24997439</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaziri</surname><given-names>S</given-names></name><name><surname>Jamshidifar</surname><given-names>Z</given-names></name><name><surname>Darbani</surname><given-names>SA</given-names></name></person-group><article-title>The effectiveness of cognitive group therapy decreasing the symptoms of depression</article-title><source>Procedia&#x02014;Social and Behavioral Sciences</source><year>2011</year><volume>30</volume><fpage>2173</fpage><lpage>2179</lpage></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macrodimitris</surname><given-names>S</given-names></name><name><surname>Wershler</surname><given-names>J</given-names></name><name><surname>Hatfield</surname><given-names>M</given-names></name><name><surname>Hamilton</surname><given-names>K</given-names></name><name><surname>Backs-Dermott</surname><given-names>B</given-names></name><name><surname>Mothersill</surname><given-names>K</given-names></name><etal/></person-group><article-title>Group cognitive-behavioral therapy for patients with epilepsy and comorbid depression and anxiety</article-title><source>Epilepsy Behav</source><year>2011</year><volume>20</volume><fpage>83</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">21131237</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hynninen</surname><given-names>MJ</given-names></name><name><surname>Bjerke</surname><given-names>N</given-names></name><name><surname>Pallesen</surname><given-names>S</given-names></name><name><surname>Bakke</surname><given-names>PS</given-names></name><name><surname>Nordhus</surname><given-names>AH</given-names></name></person-group><article-title>A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD</article-title><source>Resp Med</source><year>2010</year><volume>104</volume><fpage>986</fpage><lpage>994</lpage></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>LB</given-names></name></person-group><source>Experimental methodology</source><year>2001</year><edition>8th ed. </edition><publisher-loc>Boston</publisher-loc><publisher-name>Allyn and Bacon</publisher-name></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahebi</surname><given-names>A</given-names></name><name><surname>Asghari</surname><given-names>MJ</given-names></name><name><surname>Salari</surname><given-names>RS</given-names></name></person-group><article-title>Validation of depression anxiety and stress scale (DASS-21) for an Iranian population</article-title><source>Journal of Iranian Psychologists</source><year>2005</year><volume>1</volume><fpage>299</fpage><lpage>312</lpage></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>TA</given-names></name><name><surname>Di</surname><given-names>Nardo PA</given-names></name><name><surname>Barlow</surname><given-names>DH</given-names></name></person-group><article-title>Anxiety disorders interview schedule</article-title><year>1994</year><edition>4th ed. </edition><publisher-loc>Boulder</publisher-loc><publisher-name>Graywind</publisher-name></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gollan</surname><given-names>J</given-names></name><name><surname>Atlis</surname><given-names>M</given-names></name><name><surname>Marlow-O&#x02019;Connor</surname><given-names>M</given-names></name></person-group><source>Behavioral activation: Group treatment for depression (pilot version). Unpublished manual</source><year>2003</year><publisher-loc>Chicago</publisher-loc><publisher-name>University of Chicago</publisher-name></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Martell</surname><given-names>CR</given-names></name><name><surname>Dimidjian</surname><given-names>S</given-names></name><name><surname>Herman-Dunn</surname><given-names>R</given-names></name></person-group><article-title>Behavioral activation for depression: a clinician&#x02019;s guide</article-title><year>2010</year><publisher-loc>New York</publisher-loc><publisher-name>Guilford</publisher-name></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rachman</surname><given-names>S</given-names></name></person-group><article-title>Psychological treatment of anxiety: the evolution of behavioral therapy and cognitive behavioral therapy</article-title><source>Annu Rev Clin Psychol</source><year>2009</year><volume>5</volume><fpage>97</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">19086834</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Akhond-Makkeie</surname><given-names>Z</given-names></name><name><surname>Sanaiezaker</surname><given-names>B</given-names></name></person-group><source>The effect of group cognitive therapy based on Beck&#x02019;s procedure to treat depressed 15&#x02013;17 year-old teen girls at ShahinShahr in Isfehan city Unpublished master&#x02019;s thesis</source><year>1997</year><publisher-loc>Tehran</publisher-loc><publisher-name>University of Tarbiat Moallem</publisher-name></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Izadi</surname><given-names>M</given-names></name><name><surname>Sanaie</surname><given-names>B</given-names></name><name><surname>Kianmanesh</surname><given-names>A</given-names></name></person-group><source>The effect of developmental-cognitive therapy on trait and state anxiety in two groups of 19&#x02013;29 year-old boys and girls at Ahvaz city. Unpublished master&#x02019;s thesis</source><year>2002</year><publisher-loc>Tehran</publisher-loc><publisher-name>University of Tarbiat Moallem</publisher-name></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Joharifard</surname><given-names>R</given-names></name></person-group><source>The effect of group cognitive-behavioral therapy in patients with generalized anxiety disorder. Unpublished master&#x02019;s thesis</source><year>2005</year><publisher-loc>Shiraz</publisher-loc><publisher-name>Shiraz University</publisher-name></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Komeili-Sani</surname><given-names>H</given-names></name><name><surname>Dejkam</surname><given-names>M</given-names></name></person-group><source>Effect of cognitive therapy in depression rate of nursing students at Abadan nursing and obstetrics faculty at academic year 1995&#x02013;96. Unpublished master&#x02019;s thesis</source><year>1996</year><publisher-loc>Tehran</publisher-loc><publisher-name>University of Tarbiat Modarres</publisher-name></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mundt</surname><given-names>JC</given-names></name><name><surname>Marks</surname><given-names>IM</given-names></name><name><surname>Shear</surname><given-names>MK</given-names></name><name><surname>Greist</surname><given-names>JH</given-names></name></person-group><article-title>The work and social adjustment scale: a simple measure of impairment in functioning</article-title><source> Brit J Psychiat</source><year>2002</year><volume>180</volume><fpage>461</fpage><lpage>464</lpage></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Free</surname><given-names>ML</given-names></name></person-group><source>Cognitive therapy in groups: guidelines and resources for practice</source><year>1999</year><publisher-loc>Chichester</publisher-loc><publisher-name>Wiley</publisher-name></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lovibond</surname><given-names>SM</given-names></name><name><surname>Lovibond</surname><given-names>PFM</given-names></name></person-group><source>Manual for the Depression Anxiety Stress Scales</source><year>1995</year><edition>2nd ed</edition><publisher-loc>Sydney</publisher-loc><publisher-name>Psychology Foundation</publisher-name></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakhshipour</surname><given-names>A</given-names></name><name><surname>Dejkam</surname><given-names>M</given-names></name></person-group><article-title>Confirmatory factor analysis of the Positive and Negative Affect Scale</article-title><source>J Psychol</source><year>2006</year><volume>9</volume><fpage>351</fpage><lpage>365</lpage></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>TA</given-names></name><name><surname>Di</surname><given-names>Nardo, PA</given-names></name><name><surname>Lehman</surname><given-names>CL</given-names></name><name><surname>Campbell</surname><given-names>LA</given-names></name></person-group><article-title>Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders</article-title><source>J Abnorm Psychol</source><year>2001</year><volume>110</volume><fpage>49</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">11261399</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Borenstein</surname><given-names>M</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Cooper</surname><given-names>H</given-names></name><name><surname>Hedages</surname><given-names>LV</given-names></name><name><surname>Valentine</surname><given-names>JC</given-names></name></person-group><article-title>Effect sizes for continuous data</article-title><source>The handbook of research synthesis and meta-analysis</source><year>2009</year><publisher-loc>New York</publisher-loc><publisher-name>Russell Sage Foundation</publisher-name></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobson</surname><given-names>NS</given-names></name><name><surname>Truax</surname><given-names>PA</given-names></name></person-group><article-title>Clinical significance: a statistical approach to defining meaningful change in psychotherapy research</article-title><source>J Consult Clin Psych</source><year>1991</year><volume>59</volume><fpage>12</fpage><lpage>19</lpage></element-citation></ref></ref-list></back></article>